Sea Pharmaceuticals has filed a notice of an exempt offering of securities to raise $2,175,701.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Sea Pharmaceuticals is raising $2,175,701.00 in new funding. Sources indicate that as part of senior management President, James Pearson played a key role in securing…
